19 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
27
Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors.

Celera Genomics
3
Development of activity-based probes for trypsin-family serine proteases.

Celera Genomics
5
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

University of Florida
16
Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.

Johnson & Johnson Pharmaceutical Research & Development
1
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors.

Celera Genomics
27
Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase.

Aventis Pharmaceuticals
14
Combinatorial approaches towards the discovery of new tryptase inhibitors.

University of Barcelona
5
Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human beta-tryptase.

Aventis Pharmaceuticals
15
Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.

Aventis Pharmaceuticals
7
Bivalent inhibition of beta-tryptase: distance scan of neighboring subunits by dibasic inhibitors.

Institut FüR Biochemie
30
Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.

Axys Pharmaceuticals
18
Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.

Axys Pharmaceuticals
40
Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors.

Roche Pharma Research and Early Development
17
Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.

Novartis Institutes For Biomedical Research
14
Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase.

Weill Cornell Medicine
83
Amide derivatives as lysophosphatidic acid receptor antagonists

Takeda Pharmaceutical
60
Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands

Laboratorios Del Dr. Esteve
19
Imidazopyridyl compounds as aldosterone synthase inhibitors

Merck Sharp & Dohme
10
Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.

Biocryst Pharmaceuticals